Pramirol SR 3.15 Tablet
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Pramipexole (3.15mg)
Overview Pramirol SR 3.15 Tablet
Pramipexole extended-release 3.15mg tablets manage Parkinson's disease and restless legs syndrome (characterized by an irresistible urge to move legs, often due to unpleasant sensations). This medication reduces tremor by moderating body movements. Administer Pramipexole 3.15mg tablets with food, consistently at the same time daily for optimal blood levels. Follow your doctor's prescribed dosage and duration; if a dose is missed, take it immediately upon remembering. Complete the entire course of treatment, even if symptoms improve, and never discontinue use abruptly without consulting your physician. Potential side effects include nausea, dry mouth, tiredness, visual disturbances, bowel irregularity, and fluid retention in the extremities. Drowsiness and dizziness are also possible; avoid driving or mentally demanding tasks until the effects are known. Report any unusual shifts in mood, hypersexuality, compulsive gambling, or excessive spending to your doctor, as these can be serious.
Primary Ingredients of Pramirol SR 3.15 Tablet
No text was provided to rewrite.
Uses of Pramirol SR 3.15 Tablet
Parkinson's disease and restless legs syndrome
Major Benefits of Pramirol SR 3.15 Tablet:
Follow your doctor's instructions or refer to the product label for usage guidance. Consume Pramirol SR 3.15 Tablet with a meal.
Common Side effects of Pramirol SR 3.15 Tablet:
- Dizziness
- Sleepiness
- Nausea
- Dryness in mouth
- Fatigue
- Hallucination
- Constipation
- Peripheral edema
- Muscle spasm
How to use Pramirol SR 3.15 Tablet:
Follow your physician's instructions or consult the product information leaflet for dosage details. Ingestion of Pramirol SR 3.15mg Tablets should coincide with meals.
How Pramirol SR 3.15 Tablet works:
Pramirol SR 3.15mg tablets function by replicating the effects of dopamine, a neurotransmitter crucial for regulating motor control within the brain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Pramirol SR 3.15mg tablets and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Extended-release pramipexole (3.15 mg) tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against the risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Pramirol SR 3.15 Tablet while breastfeeding is likely unsafe. Available human data indicates potential transfer of the drug into breast milk, posing a risk to the infant. This medication's prolactin-suppressing effect may negatively impact lactation.
DrivingUNSAFE
Driving ability may be impaired by Pramirol SR 3.15 Tablet, a medication that can induce hallucinations—perceptual disturbances involving sights, sounds, or sensations lacking external stimuli.
KidneyCAUTION
Exercise caution when administering Pramirol SR 3.15 Tablets to individuals with impaired renal function. Dosage modification for Pramirol SR 3.15 Tablets might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Pramirol SR 3.15 Tablet in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Pramirol SR 3.15 Tablet :
Omit any missed Pramirol SR 3.15 Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Pramirol SR 3.15 Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzothiazole compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Actions | Dopamine-stimulating medications |






